PTPN11 and juvenile myelomonocytic leukemia: Also, mouse and patients cells with Juvenile Myelomonocytic Leukemia (JMML) bearing E76K SHP2 are more sensitive to LY6 than wild-type cells, highlighting its possible use for the treatment of PTPN11-associated malignancies [141].